This relates to Design Verification testing for a complex electromechanical medical device (only 5 test articles on hand, we have to rely on repeats to get to n=30). It does not relate to ongoing process control!
Our procedures ask for data normality testing prior to calculation of Ppk values (or equivalent tolerance interval testing) for the given % reliability and % confidence (which are driven by DFMEA risk levels). However in many cases the data is extraordinarily capable (e.g. Ppk would be 50 or more!) but due to the lack of variation within individual test articles it fails normality check. Transformation or fitting to another non-normal distribution isn't working either for the same reason.
Obviously I have no concern about the design's ability to meet the defined requirement, but at the minute I have to 'fail' the test.
QUESTION: is anyone aware of any guidance/standard which might say something like "for Ppk levels greater than 2.00, normality testing is not required"? Or to spin the math around another way, instead of our 95%/95% acceptance criteria, could we do tolerance interval testing for something like 99.9%/95% without the normality check?
I have also considered:
I suspect I will be lectured (hi Bev) on 'misuse of Ppk' but (dare I say it) this is part of the game in medical device design verification, when dealing with low risk requirements which we have high confidence in meeting! We just need a good reference to appease the regulators!
Thanks
Our procedures ask for data normality testing prior to calculation of Ppk values (or equivalent tolerance interval testing) for the given % reliability and % confidence (which are driven by DFMEA risk levels). However in many cases the data is extraordinarily capable (e.g. Ppk would be 50 or more!) but due to the lack of variation within individual test articles it fails normality check. Transformation or fitting to another non-normal distribution isn't working either for the same reason.
Obviously I have no concern about the design's ability to meet the defined requirement, but at the minute I have to 'fail' the test.
QUESTION: is anyone aware of any guidance/standard which might say something like "for Ppk levels greater than 2.00, normality testing is not required"? Or to spin the math around another way, instead of our 95%/95% acceptance criteria, could we do tolerance interval testing for something like 99.9%/95% without the normality check?
I have also considered:
- Attribute sampling - not practical where reliability is 99% as I need n=299 per Bayes success-run theorem.
- Writing a justification that "we expect the data to be normally distributed, but due to special causes x/y/z the data in this case fails normality check. The data will be analysed as if it were normally distributed" - such subjectivity is not well received in medical device regulation.
- Remove the requirement for normality - I know this isn't right, though I mention it as (interestingly) many medical device companies I've worked at don't require it!
I suspect I will be lectured (hi Bev) on 'misuse of Ppk' but (dare I say it) this is part of the game in medical device design verification, when dealing with low risk requirements which we have high confidence in meeting! We just need a good reference to appease the regulators!
Thanks